U.S. stocks anomaly | Novo Nordisk (NVO.US) increases its bid to acquire Metsera (MTSR.US), causing a 15% surge in the stock price.

According to the Securities Times app, on Tuesday, the stock price of Metsera (MTSR.US) rose, with the stock up over 15% to $70.42 as of press time. On the news side, bidding from Pfizer (PFE.US) and Novo Nordisk (NVO.US) has been further intensified.